Publication | Open Access
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021
469
Citations
6
References
2021
Year
AsthmaAllergy MedicineImmunodeficienciesImmunologyClinical DetailsVaccine HesitancyCovid-19Vaccine SurveillanceRespiratory InfectionInfection Control2020-January 18Vaccine SafetyAllergyMedicineCovid-19 PandemicVaccine TestingMrna Covid-19 VaccinesPulmonary MedicineJama Insights ReviewAnaphylactic ReactionsVaccinationEmerging Infectious DiseasesUs—december 14Infectious Respiratory DiseaseVaccine EfficacyPrecision VaccinologyClinical Allergy
This JAMA Insights review provides clinical details of anaphylactic reactions reported to and verified by the CDC in the first month of use of the Pfizer-BioNTech and Moderna COVID-19 vaccines in the US, December 14, 2020-January 18, 2021.
| Year | Citations | |
|---|---|---|
Page 1
Page 1